---
title: "MPCSH: Vice General Manager Wang Ruoqiang resigned due to work reasons"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/257491353.md"
description: "On September 16th, MPCSH announced that the company's board of directors received a written resignation letter from Deputy General Manager Wang Ruoqiang. Due to work reasons, Wang Ruoqiang applied to resign from the position of Deputy General Manager. Wang Ruoqiang's resignation letter will take effect from the date it is delivered to the company's board of directors. After resigning from the position of Deputy General Manager, Wang Ruoqiang will no longer hold any position in the company or its holding subsidiaries"
datetime: "2025-09-16T07:52:10.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/257491353.md)
  - [en](https://longbridge.com/en/news/257491353.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/257491353.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/257491353.md) | [English](https://longbridge.com/en/news/257491353.md)


# MPCSH: Vice General Manager Wang Ruoqiang resigned due to work reasons

On September 16th, MPCSH announced that the company's board of directors received a written resignation letter from the company's deputy general manager, Wang Ruoqiang. Due to work reasons, Wang Ruoqiang applied to resign from the position of deputy general manager. Wang Ruoqiang's resignation letter will take effect from the date it is delivered to the company's board of directors. After resigning from the position of deputy general manager, Wang Ruoqiang will no longer hold any positions in the company or its holding subsidiaries

### 相關股票

- [MPCSH (000637.CN)](https://longbridge.com/zh-HK/quote/000637.CN.md)

## 相關資訊與研究

- [Franco-Nevada (NYSE:FNV) Sees Large Volume Increase Following Strong Earnings](https://longbridge.com/zh-HK/news/278761206.md)
- [Junshi Biosciences’ Subcutaneous Toripalimab NDAs Accepted in China](https://longbridge.com/zh-HK/news/278445287.md)
- [Kainova reports positive top line results from Phase I EPRAD trial](https://longbridge.com/zh-HK/news/278702903.md)
- [10:10 ETCaringKind Launches WeAreCaringKind.org & New Website, Expanding Access to Free Alzheimer's and Dementia Support](https://longbridge.com/zh-HK/news/278738105.md)
- [13:46 ETNanchang Optoelectronic Industry Cluster brilla en ISLE 2026](https://longbridge.com/zh-HK/news/278597263.md)